Dual malignancies in the setting of differentiated thyroid carcinoma: their synchronous or metachronous nature, impact of radioiodine treatment on occurrence of second malignancy and other associated variables
dc.contributor.author | Gandhi, S. | |
dc.contributor.author | Abhyankar, A. | |
dc.contributor.author | Basu, Sandip | |
dc.date.accessioned | 2014-12-22T08:05:27Z | |
dc.date.available | 2014-12-22T08:05:27Z | |
dc.date.issued | 2014 | |
dc.description.division | RMC | en |
dc.format.extent | 5964 bytes | |
dc.format.mimetype | text/html | |
dc.identifier.source | Nuclear Medicine Communications, 2014. Vol. 35 (2): pp. 205-209 | en |
dc.identifier.uri | http://hdl.handle.net/123456789/10139 | |
dc.language.iso | en | en |
dc.subject | differentiated carcinoma thyroid | en |
dc.subject | dual malignancy | en |
dc.subject | external beam radiotherapy | en |
dc.subject | metachronous | en |
dc.subject | radioiodine therapy | en |
dc.subject | second primary malignancy | en |
dc.subject | synchronous | en |
dc.title | Dual malignancies in the setting of differentiated thyroid carcinoma: their synchronous or metachronous nature, impact of radioiodine treatment on occurrence of second malignancy and other associated variables | en |
dc.type | Article | en |